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Objective: Elastoﬁbroma dorsi (ED) is a rare, benign, soft tissue tumor typically located between inferior
corner of scapula and posterior chest wall causing mass, scapular snapping, and pain. When classic
symptoms and localization are present, it is diagnosed without biopsy and treated with marginal
resection. This study retrospectively analyzed patients operated on for ED to evaluate presenting
symptoms, tumor size, complications, and clinical results, and to suggest optimal treatments.
Methods: This study included 51 patients who underwent surgery for ED in 2 different clinics between
2005 and 2015. Patient age, gender, profession, side affected, symptoms, average duration of symptoms,
and tumor size were researched. Radiological examinations of patients were evaluated. Patients with
lesions larger than 5 cm in size were operated on. Postoperative complications, recurrence, and func-
tional results were evaluated using Constant score and compared to preoperative values.
Results: A total of 61 operated lesions of 51 patients clinically and radiologically diagnosed with ED were
retrospectively evaluated. Average length of time patient experienced symptoms was 11.21 months.
Lesions in 19 (37.2%) patients were bilateral, 10 of which were symptomatic and larger than 5 cm in size,
meeting indication for surgery. Average lesion diameter was 8.7 cm. Average follow-up was 26.89
months. Average of preoperative Constant score of 67.28 subsequently increased to 92.88 (p < 0.05).
Seroma and hematoma were observed in 11.5% of patients.
Conclusion: Generally, good clinical results can be obtained with marginal resection without requiring a
biopsy, considering classic complaints and radiological appearance of ED.
Level of evidence: Level IV, Therapeutic study.
© 2016 Turkish Association of Orthopaedics and Traumatology. Publishing services by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Elastoﬁbroma dorsi (ED) is a rare, benign, connective tissue tu-
mor that grows slowly. It is frequently located between inferior
corner of scapula and posterior chest wall. ED was ﬁrst deﬁned by
Jarvi and Saxen in 1961 and is frequently observed in middle-aged
and older females.1,2 The most frequently observed symptoms of
this tumor, which is typically located adjacent to periosteum of
sixth, seventh, and eighth ribs deep in the latissimus dorsi, rhom-
boids, or serratus anterior muscles, are swelling, pain during
shoulder movements, and snapping of the scapula.
Although friction between chest wall and inferior corner of
scapula and development of trauma is most often held responsible,Deveci).
ciation of Orthopaedics and
s and Traumatology. Publishing sethe actual etiology of ED is still being discussed.3 A study of au-
topsies revealed elastoﬁbroma-like changes at a rate of 81%, which
suggested that ED may be a result of aging.4 The fact that approx-
imately half of cases were bilateral and that 30% of the patients had
ED history in their families suggested genetic cause for the disease.5
Hernandez et al found deoxyribonucleic acid (DNA) sequence los-
ses in 1p, 13p, 19p, and 22q chromosomes.6 Studies have shown an
increase in the number of DNA copies on long arm of X chromo-
some.7 Imanishi et al stated that transforming growth factor b and
basic ﬁbroblast growth factor may play a role in development of
ED.8 Tas¸lı et al reported that lesion may originate from primitive
dermal mesenchymal cells due to factor XIIIa and CD34 positivity.9
All these histological ﬁndings have revealed that ED is a real
neoplastic process rather than a degenerative disease or a result of
aging of connective tissue.rvices by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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symptoms such as increasing swelling, pain with shoulder move-
ment or in supine position, or snapping of the scapula.3 It is not a
well-demarcated lesion, and although symptomatic healing is
observed in majority of patients after marginal resection, compli-
cations such as seroma and hematoma may be observed.
Orthopedic literature consists of small case series and case re-
ports about treatment of this rare tumor. Although some authors
suggest marginal resection to relieve symptoms, due to its rarity,
optimal treatment approach and postoperative care has not been
clearly determined.3,10 This study retrospectively analyzed patients
operated on for ED to evaluate presenting symptoms, tumor size,
complications, and clinical results, and to suggest optimal
treatment.Patients and methods
With the permission of Çukurova University Faculty of Medicine
ethical board, records of 61 surgically treated lesions of 51 patients
diagnosed clinically and radiologically with ED at 2 dedicated tu-
mor centers between 2005 and 2015 were retrospectively evalu-
ated. Patient age, gender, profession, lesion side, symptoms,
average duration of symptoms, and tumor size were analyzed, and
radiological examinations were evaluated.
Surgical indications were deﬁned as tumor larger than 5 cm in
size and symptoms related to lesion. Marginal resection was per-
formed by 2 senior orthopedic oncologists (authors 1 and 2) with
the same exposure. Under general anesthesia, with patient in prone
position, ipsilateral arm was draped freely to have better localiza-
tion of lesion. Latissimus dorsi muscle was split with transverse
incision over the lesion, and serratus anterior muscle was accessed.
Hard, white tissue with uncertain margin that was ﬁrmly attached
to serratus anterior and periosteum of ribs was separated using
electrocautery, and marginal resection was performed. Suction
drain was inserted after resection with careful control of hemor-
rhage (Fig. 1). Drainwas kept in place for at least 48 h. Patients wore
arm sling for 15 days after surgery. Subsequently, passiveFig. 1. Surgical technique. (A) Mass is made clearly visible by abducting and elevating the
serratus anterior muscles. (C). Chest wall after resection. (D) Appearance after the wound wmovements were initiated; active, full range of joint motion (ROM)
was allowed in ﬁrst postoperative month. Follow-up was con-
ducted at 15 days, ﬁrst month, third month, and at intervals of 3
months for the ﬁrst 1.5 years after procedure. Recurrence was
evaluated with clinical examination at each visit, followed by ul-
trasound (US) if there was suspected lesion.
Pre- and postoperative functional results were evaluated using
Constant shoulder score, which is composed of 4 categories: pain,
ability to perform activities of daily living, ROM, and strength of
abduction. Both total score and category scores were evaluated
statistically. Complications and recurrence rates were also
analyzed.
Statistical analysis
Statistical analyses were performed using Statistical Package for
Social Sciences software, version 16.0 (SPSS Inc., Chicago, IL, USA).
Average and standard deviation were calculated for quantitative
variables, and number of cases and rates were calculated for cate-
gorical variables. Differences between pre- and postoperative
Constant score were analyzed using paired sample t-test. Chi-
square test was used to investigate correlation between tumor
size and complications. P value less than 0.05 was considered
signiﬁcant.
Results
Study patients were 6 males (11.8%) and 45 females (88.2%).
Average agewas 55.33 ± 7.01 years (range: 41e69 years). Regarding
professional occupation, 44 were housewives, 2 worked at desk
jobs, and 5 were manual laborers. All of the lesions were located in
inferior subscapular region, which is the typical location for ED. The
most frequent presenting complaint was mass that could be clearly
visualized with abduction and elevation of arm (90%) (Fig. 2), fol-
lowed by pain (73.7%) during shoulder movement, and scapular
snapping (65%). Average duration of symptoms was 11.21 ± 4.77
months (range: 4e26 months).arm in the prone position, and (B) is reached by passing through latissimus dorsi and
as closed.
Fig. 2. Mass is clearly seen on the left inferior corner of the scapula with abduction and
elevation of the arm.
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bilateral; 10 had symptomatic lesions larger than 5 cm in size and
underwent surgery. Thoracic or shoulder magnetic resonance im-
aging (MRI) was used to diagnose 58 lesions, and 3 patients (3 le-
sions) were diagnosed using thoracic computed tomography (CT).Fig. 3. Macroscopic appearancOf the lesions, 35 were on the right side and 26 were on the left.
Average lesion diameter was 8.7 ± 2.09 cm (range: 5e13 cm).
Average follow-up time was 26.89 ± 12.87 months (range: 6e60
months).
Macroscopically, ED is a hard tumor without a capsule and has
uncertain boundaries that cannot be distinguished from the muscle
and fat tissue around it (Fig. 3). Pathologically ED consists of
abnormal elastic ﬁbrils and ﬁbroblasts spread in normal collagen
ﬁber bundles (Fig. 4). None of the patients required blood
transfusion.
Functional evaluation of shoulder was made using Constant
score. Average Constant score improved from 67.28 ± 6.88 (range:
52e80) before the operation to 92.88 ± 4.72 (range: 78e100) at last
follow-up (p < 0.05). Improvement in pain and activities of daily
living categories were statistically signiﬁcant (p < 0.05); no signiﬁ-
cant difference was found in ROM and abduction strength scores.
Recurrence was not observed in any of the patients. Seroma and
hematoma were observed in 4 and 3 patients, respectively (11.5%).
Six of these patients were treated only with aspiration and
compressive dressing. One was re-operated on 15 days after initial
operation and drainagewas performed due to hematoma. Therewas
no correlation between size of tumor and complications (p > 0.05).
Discussion
The literature about ED primarily consists of case reports and
small series. The present study is 1 of the largest series with func-
tional evaluation in orthopedic literature. Although ED is a rare,
benign, soft tissue tumor, its actual incidencemay be higher. Brander
et al found incidence in normal population to be 2% in CT screen-
ings.11 Rate of elastoﬁbroma seen in the autopsy series was 11.2% in
males and 24.4% in females older than 55 years of age.12 Majority of
patients were housewives in the present series; 37.2% of cases
showed bilateral ED, but only 19.6% underwent resection. Bilateral
involvement of ED is reported between 12 to 73% of cases.13
Pain and snapping in scapula are the most frequent symptoms,
accompanied by swelling. Hammoumi et al reported 93% pain,
51.3% functional limitation, and 31% clicking or lump in a series of
76 cases.14 Due to the variety of clinical signs, ED may bee of elastoﬁbroma dorsi.
Fig. 4. (A) Bent or globoid elastic ﬁbers and rare ﬁbroblasts are visible in imaging degenerated with eosinophilic thick collagen (H&E, 200). (B) Extending and globoid elastic ﬁbers
observed using Verhoeffevan Gieson's histochemical dye.
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cases it is detected during CT and MRI performed for another
complaint, this deeply located lesion generally is not diagnosed
unless it reaches a size larger than 5 cm. The sources of symptomsFig. 5. (A) Axial T1 sequence shows isointense mass between scapula and thoracic waexperienced at age when cervical vertebrae and shoulder problems
are frequently observed should be evaluated carefully with a
meticulous physical examination, and cases incidentally diagnosed
with imaging methods should be separated.ll. (B) Heterogenous contrast enhancement of lesion in T1 fat saturation sequence.
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Although lesion may be underdiagnosed radiologically, Malghem
et al described a non-encapsulated lesion in typical location be-
tween ﬁbrous tissue and fat tissue that showed an alternating
pattern on MRI. While ﬁbrous tissue showed low signal intensity in
T1 and T2 sequences, fat tissue showed high signal intensity in T1
sequence. The areas that enhance or do not enhance can be seen in
contrast series. Fat tissue is seen as lines in ﬁbrous tissue parallel to
chest wall.15 One study categorized ED into 3 subgroups based on
MRI ﬁndings. Type A is inhomogeneous, fasciculated type; type B is
inhomogeneous, non-speciﬁc type; and type 3 is isointense type
with homogeneous muscle. Average positive predictive value and
sensitivity were found to be 93.3% and 100%, respectively.16 US is 1
of the diagnostic modalities used in typical cases. A well-
demarcated multilayer eco-signal is noted.17 Studies conducted
using positron emission tomography/computed tomography (PET/
CT) found that ED had a diffuse but slight 18F-ﬂuorodeoxyglucose
involvement. Studies found average standardized uptake value to
be 2.29.18 Blumenkrantz found 1.66% ED in 1751 patients under-
going PET/CT.19
The typical location of the tumor, long-term symptoms, and
typical radiological ﬁndings, particularly MRI, are generally sufﬁ-
cient for ED diagnosis. Biopsy is generally not necessary with these
ﬁndings. There is no evidence of malignant transformation of ED.
Alberghini reported a case having high spindle cell sarcoma
together with ED.20 Therefore, lipoma, hemangioma, and soft tissue
sarcoma should be kept in mind for differential diagnosis in cases
where there is rapid growth, signiﬁcant contrast involvement, and
atypical location.
The limit for surgical indication is still being discussed; however,
generally accepted indications for resection are symptomatic cases
with lesions larger than 5 cm in size, as in present study. Some
authors suggest resection of all symptomatic and asymptomatic
cases in order to conﬁrm diagnosis pathologically.3 As it is a slow-
growing tumor and diagnosis can be made with typical localization
and radiology, surgery is not indicated in asymptomatic lesions.
Resection with scapulothoracic joint arthroscopy has been
described for selected cases.21
After marginal resection, all complaints resolved totally and
functional result was statistically improved. The most dramatic
difference was seen in pain and daily living activity sections of
Constant score. Abat et al reported signiﬁcant improvement in pain
and shoulder antepulsion.22 Parrat et al stated that visual analogue
scale score improved from 4.6 to 2.4 postoperatively and Instability
Classiﬁcation (Stanmore) score of 78.1 after follow-up of 4.6 years.
Forward ﬂexionwas the onlymovement found to be improved after
surgery.10
The most frequently reported complications after resection of
ED are hematoma and seroma. Nanago et al reported instance of
hematoma as high as 43% and found that tumor diameter was
related to development of hematoma.3 A verymeticulous control of
hemorrhage and keeping drain in place for sufﬁcient length of time
after resection in event of excessive hemorrhage in the chest wall
can decrease these complications.22 There is no consensus in the
literature about rehabilitation protocol after surgery. Nagano rec-
ommends immobilization for 1 week.3 We started passive ROM
exercises after 15 days, whichmay seem to be quite a long time, but
immobilization can help healing of muscle reattachments and can
stabilize ﬂaps, thereby helping to reduce complications.
No recurrence was observed in this series. Nagamine reported
0.06% recurrence in his series of 170 cases, and Lucaca reported 4.5%
recurrence in his series of 71 cases.23,24
The retrospective nature, and lack of randomization and control
group are limitations of this study; however, large number of cases
and long follow-up period make this study valuable.In conclusion, ED is a rare, slow-growing, soft tissue tumor
typically located in scapulothoracic region at lower corner of
scapula. Generally, good clinical results can be obtained using
marginal resection without requiring a biopsy, considering classic
complaints and radiological appearance of ED. Attention should be
paid to complications such as hematoma and seroma. Resection
decision should be made based on discussion with patient and
thorough evaluation of symptoms of each case.Conﬂicts of interest
None declared.References
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